Authors:
Kohleisen, B
Hutzler, P
Shumay, E
Ovod, V
Erfle, V
Citation: B. Kohleisen et al., HIV-1 Nef co-localizes with the astrocyte-specific cytoskeleton protein GFAP in persistently nef-expressing human astrocytes, J NEUROVIRO, 7(1), 2001, pp. 52-55
Authors:
Kramer-Hammerle, S
Kohleisen, B
Hohenadl, C
Shumay, E
Becker, I
Erfle, V
Schmidt, J
Citation: S. Kramer-hammerle et al., HIV type 1 Nef promotes neoplastic transformation of immortalized neural cells, AIDS RES H, 17(7), 2001, pp. 597-602
Authors:
Nilsson, C
Makitalo, B
Berglund, P
Bex, F
Liljestrom, P
Sutter, G
Erfle, V
ten Haaft, P
Heeney, J
Biberfeld, G
Thorstensson, R
Citation: C. Nilsson et al., Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara, VACCINE, 19(25-26), 2001, pp. 3526-3536
Authors:
Schon, U
Seifarth, W
Baust, C
Hohenadl, C
Erfle, V
Leib-Mosch, C
Citation: U. Schon et al., Cell type-specific expression and promoter activity of human endogenous retroviral long terminal repeats, VIROLOGY, 279(1), 2001, pp. 280-291
Authors:
Sharpe, S
Polyanskaya, N
Dennis, M
Sutter, G
Hanke, T
Erfle, V
Hirsch, V
Cranage, M
Citation: S. Sharpe et al., Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity, J GEN VIROL, 82, 2001, pp. 2215-2223
Authors:
Neumann, M
Afonina, E
Ceccherini-Silberstein, F
Schlicht, S
Erfle, V
Pavlakis, GN
Brack-Werner, R
Citation: M. Neumann et al., Nucleocytoplasmic transport in human astrocytes: decreased nuclear uptake of the HIV Rev shuttle protein, J CELL SCI, 114(9), 2001, pp. 1717-1729
Authors:
Mack, M
Kleinschmidt, A
Bruhl, H
Klier, C
Nelson, PJ
Cihak, J
Plachy, J
Stangassinger, M
Erfle, V
Schlondorff, D
Citation: M. Mack et al., Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: A mechanism for cellular human immunodeficiency virus 1 infection, NAT MED, 6(7), 2000, pp. 769
Authors:
Staib, C
Drexler, I
Ohlmann, M
Wintersperger, S
Erfle, V
Sutter, G
Citation: C. Staib et al., Transient host range selection for genetic engineering of modified vaccinia virus Ankara, BIOTECHNIQU, 28(6), 2000, pp. 1137
Authors:
Sporer, B
Koedel, U
Paul, R
Kohleisen, B
Erfle, V
Fontana, A
Pfister, HW
Citation: B. Sporer et al., Human immunodeficiency virus type-1 Nef protein induces blood-brain barrier disruption in the rat: role of matrix metalloproteinase-9, J NEUROIMM, 102(2), 2000, pp. 125-130
Authors:
Sandberg, JK
Leandersson, AC
Devito, C
Kohleisen, B
Erfle, V
Achour, A
Levi, M
Schwartz, S
Karre, K
Wahren, B
Hinkula, J
Citation: Jk. Sandberg et al., Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization, VIROLOGY, 273(1), 2000, pp. 112-119
Authors:
Graham, VV
Sutter, G
Jose, MV
Garcia-Carranca, A
Erfle, V
Mendoza, NM
Merchant, H
Rosales, R
Citation: Vv. Graham et al., Human tumor growth is inhibited by a vaccinia virus carrying the E2 gene of bovine papillomavirus, CANCER, 88(7), 2000, pp. 1650-1662
Authors:
Drexler, I
Heller, K
Ohlmann, M
Erfle, V
Sutter, G
Citation: I. Drexler et al., Recombinant vaccinia virus MVA for generation and analysis of T cell responses against tumor associated antigens, METH MOL M, 35, 2000, pp. 57-73
Authors:
Ambrosini, E
Slepko, N
Kohleisen, B
Shumay, E
Erfle, V
Aloisi, F
Levi, G
Citation: E. Ambrosini et al., HIV-1 Nef alters the expression of beta II and epsilon isoforms of proteinkinase C and the activation of the long terminal repeat promoter in human astrocytoma cells, GLIA, 27(2), 1999, pp. 143-151
Authors:
Ambrosini, E
Ceccherini-Silberstein, F
Erfle, V
Aloisi, F
Levi, G
Citation: E. Ambrosini et al., Gene transfer in astrocytes: Comparison between different delivering methods and expression of the HIV-1 protein Nef, J NEUROSC R, 55(5), 1999, pp. 569-577
Authors:
Kohleisen, B
Shumay, E
Sutter, G
Foerster, R
Brack-Werner, R
Nuesse, M
Erfle, V
Citation: B. Kohleisen et al., Stable expression of HIV-1 Nef induces changes in growth properties and activation state of human astrocytes, AIDS, 13(17), 1999, pp. 2331-2341
Authors:
Goebel, FD
Mannhalter, JW
Belshe, RB
Eibl, MM
Grob, PJ
de Gruttolae, V
Griffiths, PD
Erfle, V
Kunschak, M
Engl, W
Citation: Fd. Goebel et al., Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of alarge randomized, controlled trial, AIDS, 13(12), 1999, pp. 1461-1468
Authors:
Osterhaus, ADME
van Baalen, CA
Gruters, RA
Schutten, M
Siebelink, CHJ
Hulskotte, EGJ
Tijhaar, EJ
Randall, RER
van Amerongen, G
Fleuchaus, A
Erfle, V
Sutter, G
Citation: Adme. Osterhaus et al., Vaccination with Rev and Tat against AIDS, VACCINE, 17(20-21), 1999, pp. 2713-2714
Authors:
Rosenwirth, B
Bogers, WMJM
Nieuwenhuis, IG
Ten Haaft, P
Niphuis, H
Kuhn, EM
Bischofberger, N
Erfle, V
Sutter, G
Berglund, P
Liljestrom, P
Uberla, K
Heeney, JL
Citation: B. Rosenwirth et al., An anti-HIV strategy combining chemotherapy and therapeutic vaccination, J MED PRIM, 28(4-5), 1999, pp. 195-205
Authors:
Hesse, I
Luz, A
Kohleisen, B
Erfle, V
Schmidt, J
Citation: I. Hesse et al., Prenatal transmission and pathogenicity of endogenous ecotropic murine leukemia virus Akv, LAB ANIM SC, 49(5), 1999, pp. 488-495
Authors:
Ludwig, E
Ceccherini-Silberstein, F
van Empel, J
Erfle, V
Neumann, M
Brack-Werner, R
Citation: E. Ludwig et al., Diminished Rev-mediated stimulation of human immunodeficiency virus type 1protein synthesis is a hallmark of human astrocytes, J VIROLOGY, 73(10), 1999, pp. 8279-8289
Authors:
Hohenadl, C
Germaier, H
Walchner, M
Hagenhofer, M
Herrmann, M
Sturzl, M
Kind, P
Hehlmann, R
Erfle, V
Leib-Mosch, C
Citation: C. Hohenadl et al., Transcriptional activation of endogenous retroviral sequences in human epidermal keratinocytes by UVB irradiation, J INVES DER, 113(4), 1999, pp. 587-594
Authors:
Koedel, U
Kohleisen, B
Sporer, B
Lahrtz, F
Ovod, V
Fontana, A
Erfle, V
Pfister, HW
Citation: U. Koedel et al., HIV type 1 Nef protein is a viral factor for leukocyte recruitment into the central nervous system, J IMMUNOL, 163(3), 1999, pp. 1237-1245
Authors:
Drexler, I
Antunes, E
Schmitz, M
Wolfel, T
Huber, C
Erfle, V
Rieber, P
Theobald, M
Sutter, G
Citation: I. Drexler et al., Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: Induction of tyrosinase- and melanoma-specific human leukocyte antigen A0201-restricted cytotoxic T cells in vitro and in vivo, CANCER RES, 59(19), 1999, pp. 4955-4963
Authors:
Schmidt, J
Lumniczky, K
Tzschaschel, BD
Guenther, HL
Luz, A
Riemann, S
Gimbel, W
Erfle, V
Erben, RG
Citation: J. Schmidt et al., Onset and dynamics of osteosclerosis in mice induced by Reilly-Finkel-Biskis (RFB) murine leukemia virus - Increase in bone mass precedes lymphomagenesis, AM J PATH, 155(2), 1999, pp. 557-570
Authors:
Di Nicola, M
Siena, S
Bregni, M
Longoni, P
Magni, M
Milanesi, M
Matteucci, P
Mortarini, R
Anichini, A
Parmiani, G
Drexler, I
Erfle, V
Sutter, G
Gianni, AM
Citation: M. Di Nicola et al., Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors, CANC GENE T, 5(6), 1998, pp. 350-356